Skip to main content
. 2012 Feb 20;15(2):122–126. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2012.02.11

1.

入组病人基本人口学和临床资料

Baseline demographics and clinical characteristics of patients

Gender Age
(year)
Efficacy Chemotherapy regimen/
cycles
Chemotherapy PFS
(month)
Tarceva PFS
(month)
Vandetanib PFS (month) OS
(month)
PFS: progression free survival; OS: overall survival; SD: stable disease; PD: progressive disease.
1 Female 34 SD GP1, NP1 15 22 7.5 Following
2 Female 48 SD DC1, GC3 9 14 11 24
3 Male 45 PD GC4 4 10 1.5 28
4 Male 26 PD GC4 5 2 2 16
5 Female 61 PD TC2 1.5 1 0.5 5